Hepatic IκBζpromotes alcohol-associated liver disease and acute hepatitis by enhancing CXCL1-Mediated neutrophil infiltration
文献类型:期刊论文
| 作者 | Liu, Li5,6; Qian, Shengying4,6; Li, Wenjun5; Dong, Siyue5; Ya, Ru4,6; He, Yanghuan3; Huang, Haohua2; Chen, Yingfen4,6; Ma, Ningning4,6; Hao, Yawen4,6 |
| 刊名 | FREE RADICAL BIOLOGY AND MEDICINE
![]() |
| 出版日期 | 2025-09-01 |
| 卷号 | 237页码:558-569 |
| 关键词 | Nfkbiz ALD Acute liver injury GalNac |
| ISSN号 | 0891-5849 |
| DOI | 10.1016/j.freeradbiomed.2025.06.022 |
| 英文摘要 | Background & aims: Neutrophil infiltration is a critical driver of liver injury; however, the factors regulating neutrophil recruitment remain incompletely understood. I kappa B zeta, encoded by Nfkbiz, is a key transcriptional factor known to influence the inflammatory response. This study aims to investigate whether I kappa B zeta contributes to liver injury and how it affects neutrophil infiltration. Methods: Liver-specific Nfkbiz knockout mice (Nfkbiz triangle Hep) and control mice (Nfkbizf/f) were generated and subjected to various liver disease models. RNA sequencing and chromatin immunoprecipitation (ChIP) assays were used to identify molecular targets of I kappa B zeta. Results: We found that Nfkbiz mRNA levels were significantly elevated in the livers of patients with severe alcohol-associated hepatitis and in mouse models of alcohol-associated liver disease (ALD). This elevation correlated with alanine aminotransferase (ALT) levels. Notably, hepatocyte-specific Nfkbiz deficiency reduced neutrophil infiltration and mitigated liver injury and inflammation following Gao-binge alcohol feeding. Transcriptomic and ChIP assays identified chemokine (C-X-C motif) ligand 1 (Cxcl1) as a direct downstream target of I kappa B zeta. Furthermore, Nfkbiz triangle Hep mice were also more resistant to concanavalin A (ConA)-induced hepatitis but not acetaminophen or carbon tetrachloride-induced acute liver injury, showing decreased neutrophil infiltration and reduced CXCL1 expression. Finally, therapeutic inhibition of I kappa B zeta using GalNac-siNfkbiz injection alleviated ALDrelated liver injury and inflammation, suggesting its potential as a novel therapeutic approach for ALD and other liver diseases characterized by neutrophilic inflammation. |
| WOS关键词 | INJURY |
| 资助项目 | National Key Research and Development Program of China[2023YFA1800804] ; National Science and Technology Innovation 2030 Major Program, China[2024ZD0530604] ; National Natural Science Foundation of China, China[82270601] ; National Natural Science Foundation of China, China[82270596] |
| WOS研究方向 | Biochemistry & Molecular Biology ; Endocrinology & Metabolism |
| 语种 | 英语 |
| WOS记录号 | WOS:001513942200002 |
| 出版者 | ELSEVIER SCIENCE INC |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/318630] ![]() |
| 专题 | 新药研究国家重点实验室 |
| 通讯作者 | Wang, Xiaolin; He, Yong |
| 作者单位 | 1.Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN USA 2.Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Infect Dis, Sch Med, Shanghai, Peoples R China 3.Fudan Univ, Huadong Hosp, Dept Gastroenterol, Shanghai, Peoples R China 4.Univ Chinese Acad Sci, Beijing, Peoples R China 5.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing, Peoples R China 6.Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med SIMM, Shanghai, Peoples R China |
| 推荐引用方式 GB/T 7714 | Liu, Li,Qian, Shengying,Li, Wenjun,et al. Hepatic IκBζpromotes alcohol-associated liver disease and acute hepatitis by enhancing CXCL1-Mediated neutrophil infiltration[J]. FREE RADICAL BIOLOGY AND MEDICINE,2025,237:558-569. |
| APA | Liu, Li.,Qian, Shengying.,Li, Wenjun.,Dong, Siyue.,Ya, Ru.,...&He, Yong.(2025).Hepatic IκBζpromotes alcohol-associated liver disease and acute hepatitis by enhancing CXCL1-Mediated neutrophil infiltration.FREE RADICAL BIOLOGY AND MEDICINE,237,558-569. |
| MLA | Liu, Li,et al."Hepatic IκBζpromotes alcohol-associated liver disease and acute hepatitis by enhancing CXCL1-Mediated neutrophil infiltration".FREE RADICAL BIOLOGY AND MEDICINE 237(2025):558-569. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。

